Assessing whether low- or high-dose aspirin is better for patients with coronary artery disease will be the focus of the first clinical trial to be conducted through PCORnet, the National Patient-Centered Clinical Research Network.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors approved the trial topic and up to $10 million to fund the study.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access